Justices Won't Review Sanofi's Antitrust Suit Over EpiPen
The U.S. Supreme Court on Monday declined to review a Tenth Circuit ruling that threw out an antitrust suit from Sanofi-Aventis accusing Mylan Pharmaceuticals of using rebates and other tactics to...To view the full article, register now.
Already a subscriber? Click here to view full article